ClinicalTrials.Veeva

Menu

Early Sodium Intake in Preterm Newborns

H

Hospital del Niño "Dr. Federico Gomez Santos"

Status and phase

Completed
Phase 4

Conditions

Premature
Hyponatremia

Treatments

Drug: Sodium < 1mEq/kg/day
Drug: Sodium 5mEq/kg/day

Study type

Interventional

Funder types

Other

Identifiers

NCT04035564
01/03/18N01

Details and patient eligibility

About

Hyponatremia is a common complication among preterm infants, renal losses of sodium contribute to the development of hyponatremia in preterm newborns. Sodium imbalances impact in newborns outcome. There is controversy about the time of initiation and the requirements of sodium in premature infants. Hypothesis: early (24 hours of life) sodium supplementation (5mEq/kg/day) prevents the develop of hyponatremia in preterm infants.

Full description

This study is a randomized controlled trial in infants less than 35 weeks gestation admitted to the Newborn Intensive Care Unit at Children Hospital in Saltillo Coahuila Mexico.

Infants receive at 24 hours of life; sodium (5mEq/kg/day) versus less than 1mEq/kg/day. Weight, serum and urine sodium, serum chloride, serum and urine creatinine, serum chloride, bicarbonate and glucose are monitored daily during the first 3 days of life. Patients are assessed for hyponatremia, hypernatremia, weight change, sepsis, necrotizing enterocolitis and intraventricular hemorrhage.

Enrollment

52 patients

Sex

All

Ages

Under 24 hours old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Preterm infants <35 Weeks gestation

Exclusion criteria

  • Urinary malformations
  • Congenital abdominal wall defect
  • Intestinal atresia / obstruction
  • Congenital heart defect

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

52 participants in 2 patient groups

Sodium < 1mEq/kg/day
Active Comparator group
Description:
Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Treatment:
Drug: Sodium < 1mEq/kg/day
Sodium 5mEq/kg/day
Experimental group
Description:
Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Treatment:
Drug: Sodium 5mEq/kg/day

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems